Patents by Inventor Jennifer Phipps

Jennifer Phipps has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9482513
    Abstract: Exemplary embodiments of the present disclosure include a combined catheter-based optical coherence tomography-two-photon luminescence (OCT-TPL) imaging system. Exemplary embodiments further include methods to detect, and further characterize the distribution of cellular components (e.g., macrophage, collagen/elastin fiber, lipid droplet) in thin-cap fibroatheromas with high spatial resolution in vivo.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: November 1, 2016
    Assignee: Research Development Foundation
    Inventors: Marc Feldman, Thomas Milner, Tianyi Wang, Jennifer Phipps
  • Publication number: 20140268168
    Abstract: Exemplary embodiments of the present disclosure include a combined catheter-based optical coherence tomography-two-photon luminescence (OCT-TPL) imaging system. Exemplary embodiments further include methods to detect, and further characterize the distribution of cellular components (e.g., macrophage, collagen/elastin fiber, lipid droplet) in thin-cap fibroatheromas with high spatial resolution in vivo.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: RESEARCH DEVELOPMENT FOUNDATION
    Inventors: Marc FELDMAN, Thomas MILNER, Tianyi WANG, Jennifer PHIPPS
  • Publication number: 20050020482
    Abstract: A method for modulating gap junctions is provided. In a first step, the transcription of connexin is enhanced and the gap junction is relocalized at the cell membrane; in a second step, gap junction function is restored by properly gating the channel and/or inducing apoptosis. The method preferably comprises a providing a cell or an animal with a first compound for increasing the activity of protein kinase A (PKA) and in the second step providing the cell or animal with a second compound for specifically inhibiting or activating one or more protein kinase C (PKC) isoforms and/or for specifically inhibiting p38 MAP kinase.
    Type: Application
    Filed: June 14, 2002
    Publication date: January 27, 2005
    Inventors: Jennifer Phipps, Loubaba Belbaraka, Herve Jouishomme, Saba Siddiqi, Jaafar Belgoudi, Jennifer Arnold, Suzanne Lacelle